Braveheart
48 employees on LinkedIn · 4 known investors
Find your way into Braveheart
Sign up to see every warm intro you have to Braveheart
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Braveheart team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Braveheart develops treatments for hypertrophic cardiomyopathy and related cardiac conditions. The company focuses on improving the standard of care for patients with these disease types.
Founders & leadership
Investors · 4
How we know: a16z's portfolio · cryptobriefing.com · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Related companies · 4
Companies working in the same space as Braveheart.
In the news
Frequently asked questions
- What does Braveheart do?
- Braveheart develops treatments for hypertrophic cardiomyopathy and related cardiac conditions. The company focuses on improving the standard of care for patients with these disease types.
- Who are Braveheart's investors?
- Braveheart's investors include Andreessen Horowitz, Frazier Life Sciences, OrbiMed, Forbion.






